AMEC(SH:688012) Orient Securities·2025-04-22 05:04Investment Rating - The report maintains a "Buy" rating for the company with a target price of 226.67 CNY [3][5] Core Insights - The company has shown continuous high revenue growth, with a projected revenue of 90.7 billion CNY in 2024, representing a 45% year-on-year increase [8] - The company significantly increased its R&D investment to approximately 2.45 billion CNY in 2024, a 94% increase compared to the previous year, driven by the rising demand for new equipment [8] - The company's contract liabilities surged by 235% to approximately 2.59 billion CNY by the end of 2024, indicating strong order expectations [8] Financial Performance Summary - Revenue projections for 2025-2027 are 120.49 billion CNY, 156.24 billion CNY, and 200.09 billion CNY, with year-on-year growth rates of 33%, 30%, and 28% respectively [4][9] - The net profit attributable to the parent company is forecasted to be 24.33 billion CNY, 33.60 billion CNY, and 44.60 billion CNY for 2025-2027, with growth rates of 51%, 38%, and 33% respectively [3][9] - The gross margin is expected to stabilize around 42.3% to 44.3% over the forecast period, with a slight dip to 41.1% in 2024 due to structural changes in customer base [4][8] Equipment Sales and Market Position - The company experienced significant growth in etching equipment sales, with over 1,200 reaction chambers shipped in 2024, marking a historical high [8] - The company’s new deposition equipment has started contributing to revenue, with over 150 LPCVD reaction chambers shipped and approximately 476 million CNY in bulk orders received in 2024 [8]